Inventor · disambiguated record
Hafid Ait-Oufella
Also filed as: AIT-OUFELLA HAFID
5 granted patents·7 pending applications·5 citations·filing 2008–2022
67Inventor score
Files withINST NAT SANTE RECH MED4MALLAT ZIAD4INOTREM1INSERM (INSTITUT NAT DE LA SANTE ET DE LA RECH MEDICALE)1INSERM INSTITUT NATIONAL DE SANTE ET DE LA RECH MEDICALE1
Top patents by PatentIndex Score
12 records- 0175US9657081B2Inhibiting peptides derived from triggering receptor expressed on myeloid cells-1 (TREM-1) TREM-like transcript 1 (TLT-1) for treatment of cardiovascular diseasesINSERM (INSTITUT NAT DE LA SANTE ET DE LA RECH MEDICALE)·Filed 2013·Granted May 23, 2017·4 cites·6 claims
- 0266US12144859B2B cell depleting agent for the treatment of atherosclerosisMALLAT ZIAD·Filed 2020·Granted Nov 19, 2024·0 cites·10 claims
- 0358US2025051440A1Depletion of nk cells for the treatment of adverse post-ischemic cardiac remodelingINST NAT SANTE RECH MED·Filed 2022·Application pending·0 cites
- 0457US10948498B2Methods and kits for predicting the risk of having a cardiovascular disease or eventINOTREM·Filed 2014·Granted Mar 16, 2021·1 cites·9 claims
- 0557US2019365890A1A B Cell Depleting Agent for the Treatment of AtherosclerosisMALLAT ZIAD·Filed 2019·Application pending·0 cites
- 0656US2013224215A1A B Cell Depleting Agent for the Treatment of AtherosclerosisMALLAT ZIAD·Filed 2013·Application pending·0 cites
- 0756US2024173376A1Trem-1 inhibitors for the treatment of marfan syndromeINST NAT SANTE RECH MED·Filed 2022·Application pending·0 cites
- 0855US2025231196A1Use of trem-1 for predicting and preventing postoperative complications after cardiac surgery with cardiopulmonary by-passINST NAT SANTE RECH MED·Filed 2022·Application pending·0 cites
- 0954US8586822B2Methods for producing a non human model for aortic aneurysmTHARAUX PIERRE LOUIS·Filed 2008·Granted Nov 19, 2013·0 cites·10 claims
- 1046US2011275791A1A B Cell Depleting Agent for the Treatment of AtherosclerosisMALLAT ZIAD·Filed 2010·Application pending·0 cites
- 1143US2022275105A1Neutralizing granzyme b for providing cardioprotection in a subject who experienced a myocardial infarctionINST NAT SANTE RECH MED·Filed 2020·Application pending·0 cites
- 1234US10556953B2Agent capable of depleting CD8 T cells for the treatment of myocardial infarction or acute myocardial infarctionINSERM INSTITUT NATIONAL DE SANTE ET DE LA RECH MEDICALE·Filed 2016·Granted Feb 11, 2020·0 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when Hafid Ait-Oufella files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →